BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 36071950)

  • 1. Comparing surgical and endoscopic resection approaches for colorectal neuroendocrine tumors within the diameter range of 10-20mm: an inverse probability weighting analysis based on the SEER database.
    Xu J; Liang R; Cai Q; Liu Y; Ge X; Lai B; Mao S; Cao J; Wang J
    Front Endocrinol (Lausanne); 2024; 15():1378968. PubMed ID: 38601205
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pancreatic neuroendocrine tumors: Are tumors smaller than 2 cm truly indolent?
    Hoyos S; Posada-Moreno P; Guzman-Arango N; Chanci-Drago R; Chavez J; Andrés-Duarte A; Salazar-Ochoa S
    World J Gastrointest Oncol; 2024 May; 16(5):1756-1762. PubMed ID: 38764809
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systematic Review and Metaanalysis of Lymph Node Metastases of Resected Pancreatic Neuroendocrine Tumors.
    Tanaka M; Heckler M; Mihaljevic AL; Probst P; Klaiber U; Heger U; Schimmack S; Büchler MW; Hackert T
    Ann Surg Oncol; 2021 Mar; 28(3):1614-1624. PubMed ID: 32720049
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of Surgery on Non-Functional Pancreatic Neuroendocrine Tumors ≤2 cm: Analyses With Propensity Score-Based Inverse Probability of Treatment Weighting.
    Ye J; Wu H; Li J; Liu C
    Front Surg; 2022; 9():890564. PubMed ID: 36071950
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk Factors of Lymph Node Metastasis in Patients with Pancreatic Neuroendocrine Tumors (PNETs).
    Wang Z; Cao F; Zhang Y; Fang Y; Li F
    Gastroenterol Res Pract; 2020; 2020():1946156. PubMed ID: 33061957
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcomes of Lymph Node Dissection for Non-metastatic Pancreatic Neuroendocrine Tumors: A Propensity Score-Weighted Analysis of the National Cancer Database.
    Mao R; Zhao H; Li K; Luo S; Turner M; Cai JQ; Blazer D
    Ann Surg Oncol; 2019 Sep; 26(9):2722-2729. PubMed ID: 31209670
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The risk and prognostic factors for G1 pancreatic neuroendocrine tumors: A retrospective analysis of the SEER database.
    Wu Z; Qiu X; Zhi Y; Shi X; Lv G
    Front Oncol; 2022; 12():993524. PubMed ID: 36276109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Observational study of surgical resection in small non-functional pancreatic neuroendocrine tumors: AS SEER-based study.
    Lin J; Huang H
    Sci Rep; 2023 Aug; 13(1):12824. PubMed ID: 37550460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Population-level analysis of pancreatic neuroendocrine tumors 2 cm or less in size.
    Kuo EJ; Salem RR
    Ann Surg Oncol; 2013 Sep; 20(9):2815-21. PubMed ID: 23771245
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management and outcomes of patients for non-functioning pancreatic neuroendocrine tumours: a multi-institutional analysis.
    Du B; Wang X; Zhang W; Tan Q; Wei Y; Shao Z
    ANZ J Surg; 2022 Apr; 92(4):787-793. PubMed ID: 34723424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuroendocrine and Adrenal Tumors, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology.
    Shah MH; Goldner WS; Benson AB; Bergsland E; Blaszkowsky LS; Brock P; Chan J; Das S; Dickson PV; Fanta P; Giordano T; Halfdanarson TR; Halperin D; He J; Heaney A; Heslin MJ; Kandeel F; Kardan A; Khan SA; Kuvshinoff BW; Lieu C; Miller K; Pillarisetty VG; Reidy D; Salgado SA; Shaheen S; Soares HP; Soulen MC; Strosberg JR; Sussman CR; Trikalinos NA; Uboha NA; Vijayvergia N; Wong T; Lynn B; Hochstetler C
    J Natl Compr Canc Netw; 2021 Jul; 19(7):839-868. PubMed ID: 34340212
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic factors for the outcome of nonfunctioning pancreatic neuroendocrine tumors in MEN1: a systematic review of literature.
    Sadowski SM; Pieterman CRC; Perrier ND; Triponez F; Valk GD
    Endocr Relat Cancer; 2020 Jun; 27(6):R145-R161. PubMed ID: 32229700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The North American Neuroendocrine Tumor Society Consensus Paper on the Surgical Management of Pancreatic Neuroendocrine Tumors.
    Howe JR; Merchant NB; Conrad C; Keutgen XM; Hallet J; Drebin JA; Minter RM; Lairmore TC; Tseng JF; Zeh HJ; Libutti SK; Singh G; Lee JE; Hope TA; Kim MK; Menda Y; Halfdanarson TR; Chan JA; Pommier RF
    Pancreas; 2020 Jan; 49(1):1-33. PubMed ID: 31856076
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.